Cargando…
Assessment of in vivo versus in vitro biofilm formation of clinical methicillin-resistant Staphylococcus aureus isolates from endotracheal tubes
Our aim was to demonstrate that biofilm formation in a clinical strain of methicillin-resistant Staphylococcus aureus (MRSA) can be enhanced by environment exposure in an endotracheal tube (ETT) and to determine how it is affected by systemic treatment and atmospheric conditions. Second, we aimed to...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085380/ https://www.ncbi.nlm.nih.gov/pubmed/30093624 http://dx.doi.org/10.1038/s41598-018-30494-7 |
_version_ | 1783346314328670208 |
---|---|
author | Fernández-Barat, Laia Ben-Aicha, Soumaya Motos, Anna Vila, Jordi Marco, Francesc Rigol, Montserrat Muñoz, Laura Li Bassi, Gianluigi Ferrer, Miquel Torres, Antoni |
author_facet | Fernández-Barat, Laia Ben-Aicha, Soumaya Motos, Anna Vila, Jordi Marco, Francesc Rigol, Montserrat Muñoz, Laura Li Bassi, Gianluigi Ferrer, Miquel Torres, Antoni |
author_sort | Fernández-Barat, Laia |
collection | PubMed |
description | Our aim was to demonstrate that biofilm formation in a clinical strain of methicillin-resistant Staphylococcus aureus (MRSA) can be enhanced by environment exposure in an endotracheal tube (ETT) and to determine how it is affected by systemic treatment and atmospheric conditions. Second, we aimed to assess biofilm production dynamics after extubation. We prospectively analyzed 70 ETT samples obtained from pigs randomized to be untreated (controls, n = 20), or treated with vancomycin (n = 32) or linezolid (n = 18). A clinical MRSA strain (MRSA-in) was inoculated in pigs to create a pneumonia model, before treating with antibiotics. Tracheally intubated pigs with MRSA severe pneumonia, were mechanically ventilated for 69 ± 16 hours. All MRSA isolates retrieved from ETTs (ETT-MRSA) were tested for their in vitro biofilm production by microtiter plate assay. In vitro biofilm production of MRSA isolates was sequentially studied over the next 8 days post-extubation to assess biofilm capability dynamics over time. All experiments were performed under ambient air (O(2)) or ambient air supplemented with 5% CO(2). We collected 52 ETT-MRSA isolates (placebo N = 19, linezolid N = 11, and vancomycin N = 22) that were clonally identical to the MRSA-in. Among the ETT-MRSA isolates, biofilm production more than doubled after extubation in 40% and 50% under 5% CO(2) and O(2), respectively. Systemic antibiotic treatment during intubation did not affect this outcome. Under both atmospheric conditions, biofilm production for MRSA-in was at least doubled for 9 ETT-MRSA isolates, and assessment of these showed that biofilm production decreased progressively over a 4-day period after extubation. In conclusion, a weak biofilm producer MRSA strain significantly enhances its biofilm production within an ETT, but it is influenced by the ETT environment rather than by the systemic treatment used during intubation or by the atmospheric conditions used for bacterial growth. |
format | Online Article Text |
id | pubmed-6085380 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-60853802018-08-16 Assessment of in vivo versus in vitro biofilm formation of clinical methicillin-resistant Staphylococcus aureus isolates from endotracheal tubes Fernández-Barat, Laia Ben-Aicha, Soumaya Motos, Anna Vila, Jordi Marco, Francesc Rigol, Montserrat Muñoz, Laura Li Bassi, Gianluigi Ferrer, Miquel Torres, Antoni Sci Rep Article Our aim was to demonstrate that biofilm formation in a clinical strain of methicillin-resistant Staphylococcus aureus (MRSA) can be enhanced by environment exposure in an endotracheal tube (ETT) and to determine how it is affected by systemic treatment and atmospheric conditions. Second, we aimed to assess biofilm production dynamics after extubation. We prospectively analyzed 70 ETT samples obtained from pigs randomized to be untreated (controls, n = 20), or treated with vancomycin (n = 32) or linezolid (n = 18). A clinical MRSA strain (MRSA-in) was inoculated in pigs to create a pneumonia model, before treating with antibiotics. Tracheally intubated pigs with MRSA severe pneumonia, were mechanically ventilated for 69 ± 16 hours. All MRSA isolates retrieved from ETTs (ETT-MRSA) were tested for their in vitro biofilm production by microtiter plate assay. In vitro biofilm production of MRSA isolates was sequentially studied over the next 8 days post-extubation to assess biofilm capability dynamics over time. All experiments were performed under ambient air (O(2)) or ambient air supplemented with 5% CO(2). We collected 52 ETT-MRSA isolates (placebo N = 19, linezolid N = 11, and vancomycin N = 22) that were clonally identical to the MRSA-in. Among the ETT-MRSA isolates, biofilm production more than doubled after extubation in 40% and 50% under 5% CO(2) and O(2), respectively. Systemic antibiotic treatment during intubation did not affect this outcome. Under both atmospheric conditions, biofilm production for MRSA-in was at least doubled for 9 ETT-MRSA isolates, and assessment of these showed that biofilm production decreased progressively over a 4-day period after extubation. In conclusion, a weak biofilm producer MRSA strain significantly enhances its biofilm production within an ETT, but it is influenced by the ETT environment rather than by the systemic treatment used during intubation or by the atmospheric conditions used for bacterial growth. Nature Publishing Group UK 2018-08-09 /pmc/articles/PMC6085380/ /pubmed/30093624 http://dx.doi.org/10.1038/s41598-018-30494-7 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Fernández-Barat, Laia Ben-Aicha, Soumaya Motos, Anna Vila, Jordi Marco, Francesc Rigol, Montserrat Muñoz, Laura Li Bassi, Gianluigi Ferrer, Miquel Torres, Antoni Assessment of in vivo versus in vitro biofilm formation of clinical methicillin-resistant Staphylococcus aureus isolates from endotracheal tubes |
title | Assessment of in vivo versus in vitro biofilm formation of clinical methicillin-resistant Staphylococcus aureus isolates from endotracheal tubes |
title_full | Assessment of in vivo versus in vitro biofilm formation of clinical methicillin-resistant Staphylococcus aureus isolates from endotracheal tubes |
title_fullStr | Assessment of in vivo versus in vitro biofilm formation of clinical methicillin-resistant Staphylococcus aureus isolates from endotracheal tubes |
title_full_unstemmed | Assessment of in vivo versus in vitro biofilm formation of clinical methicillin-resistant Staphylococcus aureus isolates from endotracheal tubes |
title_short | Assessment of in vivo versus in vitro biofilm formation of clinical methicillin-resistant Staphylococcus aureus isolates from endotracheal tubes |
title_sort | assessment of in vivo versus in vitro biofilm formation of clinical methicillin-resistant staphylococcus aureus isolates from endotracheal tubes |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085380/ https://www.ncbi.nlm.nih.gov/pubmed/30093624 http://dx.doi.org/10.1038/s41598-018-30494-7 |
work_keys_str_mv | AT fernandezbaratlaia assessmentofinvivoversusinvitrobiofilmformationofclinicalmethicillinresistantstaphylococcusaureusisolatesfromendotrachealtubes AT benaichasoumaya assessmentofinvivoversusinvitrobiofilmformationofclinicalmethicillinresistantstaphylococcusaureusisolatesfromendotrachealtubes AT motosanna assessmentofinvivoversusinvitrobiofilmformationofclinicalmethicillinresistantstaphylococcusaureusisolatesfromendotrachealtubes AT vilajordi assessmentofinvivoversusinvitrobiofilmformationofclinicalmethicillinresistantstaphylococcusaureusisolatesfromendotrachealtubes AT marcofrancesc assessmentofinvivoversusinvitrobiofilmformationofclinicalmethicillinresistantstaphylococcusaureusisolatesfromendotrachealtubes AT rigolmontserrat assessmentofinvivoversusinvitrobiofilmformationofclinicalmethicillinresistantstaphylococcusaureusisolatesfromendotrachealtubes AT munozlaura assessmentofinvivoversusinvitrobiofilmformationofclinicalmethicillinresistantstaphylococcusaureusisolatesfromendotrachealtubes AT libassigianluigi assessmentofinvivoversusinvitrobiofilmformationofclinicalmethicillinresistantstaphylococcusaureusisolatesfromendotrachealtubes AT ferrermiquel assessmentofinvivoversusinvitrobiofilmformationofclinicalmethicillinresistantstaphylococcusaureusisolatesfromendotrachealtubes AT torresantoni assessmentofinvivoversusinvitrobiofilmformationofclinicalmethicillinresistantstaphylococcusaureusisolatesfromendotrachealtubes |